Company / Free Cash Flow per Share
NovoCure Ltd Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.70
FY2025
5-year range
-$0.96 / $0.81
FY2021-FY2025
Trend
-7.9%
vs FY2024
Sector context
#131 of 148
Health Care
What the data says
NovoCure Ltd's free cash flow per share of $-0.70 is lower than 89% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-1.27 in FY2018 to $0.81 in FY2022.
Based on SEC 10-K filings.
-0.70 in FY2025.
Improved from $-0.96 to $-0.70 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 148This company -$0.70 Sector average $5.04
▼
-113.8% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 7.9% year-over-year.
- Ranks #131 out of 148 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2022.
- Lowest free cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.70 | -7.9% |
| FY2024 | -$0.65 | +32.4% |
| FY2023 | -$0.96 | -218.1% |
| FY2022 | $0.81 | +413.5% |
| FY2021 | $0.16 | +283.0% |
| FY2020 | -$0.09 | +80.2% |
| FY2019 | -$0.43 | +65.7% |
| FY2018 | -$1.27 | -5.4% |
| FY2017 | -$1.20 | -34.0% |
| FY2016 | -$0.90 | +78.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026